A detailed history of Northern Trust Corp transactions in Rani Therapeutics Holdings, Inc. stock. As of the latest transaction made, Northern Trust Corp holds 105,634 shares of RANI stock, worth $154,225. This represents 0.0% of its overall portfolio holdings.

Number of Shares
105,634
Previous 35,306 199.2%
Holding current value
$154,225
Previous $134,000 70.15%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$2.06 - $3.99 $144,875 - $280,608
70,328 Added 199.2%
105,634 $228,000
Q2 2024

Aug 14, 2024

BUY
$3.13 - $7.85 $29,165 - $73,146
9,318 Added 35.86%
35,306 $134,000
Q1 2024

May 14, 2024

BUY
$2.98 - $3.8 $19,569 - $24,954
6,567 Added 33.81%
25,988 $80,000
Q2 2023

Aug 11, 2023

BUY
$3.92 - $5.58 $9,035 - $12,861
2,305 Added 13.47%
19,421 $80,000
Q3 2022

Nov 14, 2022

BUY
$8.23 - $12.4 $46,795 - $70,506
5,686 Added 49.75%
17,116 $164,000
Q3 2021

Nov 15, 2021

BUY
$10.7 - $21.43 $122,300 - $244,944
11,430 New
11,430 $204,000

Others Institutions Holding RANI

About Rani Therapeutics Holdings, Inc.


  • Ticker RANI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 24,492,000
  • Market Cap $35.8M
  • Description
  • Rani Therapeutics Holdings, Inc. operates as a clinical stage biotherapeutics company that develops orally administered biologics. The company develops the RaniPill capsule, a platform that is intended to replace subcutaneous or IV injection of biologics with oral dosing. Its product pipeline includes RT-101, an octreotide, which has completed P...
More about RANI
Track This Portfolio

Track Northern Trust Corp Portfolio

Follow Northern Trust Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Northern Trust Corp, based on Form 13F filings with the SEC.

News

Stay updated on Northern Trust Corp with notifications on news.